AGRX - Agile Therapeutics Inc. (AGRX) CEO Alfred Altomari on Q3 2021 Results - Earnings Call Transcript
Agile Therapeutics, Inc. (AGRX) Q3 2021 Results Conference Call November 02 2021 04:30 PM ET Company Participants Matthew Riley - Head of Investor Relations and Corporate Communications Alfred Altomari - Chairman and Chief Executive Officer Dennis Reilly - Chief Financial Officer Conference Call Participants Leland Gershell - Oppenheimer Oren Livnat - H.C. Wainwright Timothy Lugo - William Blair & Company Presentation Operator Good afternoon, and welcome to the Agile Therapeutics’ Third Quarter 2021 Financial Results Conference Call. Please note today’s event is being recorded. I would now like to hand the conference over to Matt Riley, Head of Investors Relations. Matthew Riley Hello, everyone. And welcome to today’s conference call to discuss our third quarter 2021 financial results and corporate update. Before we start, let me remind you that today’s call will include Forward-Looking Statements based on current expectations, including statements concerning our financial outlook for the future, management’s expectations
For further details see:
Agile Therapeutics, Inc. (AGRX) CEO Alfred Altomari on Q3 2021 Results - Earnings Call Transcript